enGene Therapeutics Inc. (ENGN)
NASDAQ: ENGN · Real-Time Price · USD
1.850
-0.070 (-3.65%)
At close: Sep 9, 2026, 4:00 PM EDT
1.850
0.00 (0.00%)
After-hours: Sep 9, 2026, 4:43 PM EDT
enGene Therapeutics Employees
As of October 31, 2025, enGene Therapeutics had 82 total employees, including 81 full-time and 1 part-time employees. The number of employees increased by 25 or 43.86% compared to the previous year.
Employees
82
Change (1Y)
25
Growth (1Y)
43.86%
Revenue / Employee
n/a
Profits / Employee
-$1,589,756
Market Cap
123.93M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Oct 31, 2025 | 82 | 25 | 43.86% | 81 | 1 |
| Oct 31, 2024 | 57 | 24 | 72.73% | 56 | 1 |
| Oct 31, 2023 | 33 | - | - | 31 | 2 |
Related Stocks
| Company Name | Employees |
|---|---|
| Nautilus Biotechnology | 127 |
| Cibus | 118 |
| Rani Therapeutics Holdings | 71 |
| Connect Biopharma Holdings | 64 |
| OnKure Therapeutics | 45 |
| Vivani Medical | 42 |
| Biomea Fusion | 37 |
| TuHURA Biosciences | 22 |
ENGN News
- 1 day ago - enGene Therapeutics Transcript: Wells Fargo 21st Annual Healthcare Conference - Transcripts
- 1 day ago - enGene Reports Third Quarter 2026 Financial Results and Provides Business Update - Business Wire
- 1 day ago - enGene Therapeutics Earnings release: Q3 2026 - Filings
- 1 day ago - enGene Therapeutics Quarterly report: Q3 2026 - Filings
- 8 days ago - enGene to Participate in Upcoming Investor Conferences - Business Wire
- 4 weeks ago - enGene Therapeutics Transcript: KOL event - Transcripts
- 4 weeks ago - enGene Therapeutics Slides: KOL event - Filings
- 5 weeks ago - enGene to Host Virtual KOL Event to Discuss Emerging Non-Muscle Invasive Bladder Cancer (NMIBC) Market Insights, on August 11, 2026 - Business Wire